# Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

> **NCT01579006** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 184 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01579006
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2016-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579006, "Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01579006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*